Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study In Adults With Moderate To Severe Dermatomyositis

ClinicalTrials.gov ID: NCT03181893

Public ClinicalTrials.gov record NCT03181893. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 2 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF PF-06823859 IN ADULT SUBJECTS WITH DERMATOMYOSITIS

Study identification

NCT ID
NCT03181893
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
75 participants

Conditions and interventions

Interventions

  • PF-06823859 low Drug
  • Placebo Arm Drug
  • PF-06823859 high Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 22, 2018
Primary completion
May 26, 2022
Completion
Nov 27, 2022
Last update posted
Sep 13, 2023

2018 – 2022

United States locations

U.S. sites
35
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
The University of Alabama at Birmingham Birmingham Alabama 35249
The University of Alabama at Birmingham Birmingham Alabama 35294
Mayo Clinic Arizona Research Pharmacy Phoenix Arizona 85054
Mayo Clinic Scottsdale Arizona 85259
Attune Health Research Inc. Beverly Hills California 90211
Freidenrich Center for Translational Research at Stanford University Palo Alto California 94304
Mayo Clinic Florida Jacksonville Florida 32224
University Of Miami Hospital Miami Florida 33125
University of Miami Hospital Clinical Translational Research Site (Infusion site) Miami Florida 33136
KU Clinical Research Center - Clinical and Translational Science Unit (CTSU) Fairway Kansas 66205
The University of Kansas Medical Center Kansas City Kansas 66160
Johns Hopkins Bayview Medical Center Baltimore Maryland 21224-6821
Brigham and Women's Hospital - ACC Boston Massachusetts 02115
Brigham and Women's Hospital - CTC Boston Massachusetts 02115
Brigham and Women's Hospital - CTH Boston Massachusetts 02115
Brigham and Women's Hospital Boston Massachusetts 02115
Clinical Research Unit (CRU) Minneapolis Minnesota 55455
Department of Medicine Division of Rheumatic and Autoimmune Disease Minneapolis Minnesota 55455
Lillehei Clinical Research Unit (LCRU) Minneapolis Minnesota 55455
University of Minnesota Health Rheumatology Clinic Minneapolis Minnesota 55455
University of Minnesota, Department of Dermatology Minneapolis Minnesota 55455
Center for Outpatient Health St Louis Missouri 63108
Washington University School of Medicine St Louis Missouri 63110
New York University School of Medicine New York New York 10016
NYU Langone Health Clinical Research Center New York New York 10016
Mount Sinai Doctors Dermatology New York New York 10028
Cleveland Clinic Foundation Cleveland Ohio 44195
OHSU, Center for Health and Healing CHH2 Portland Oregon 97239
Oregon Clinical & Translational Research Institute Portland Oregon 97239
Oregon Health & Science University Portland Oregon 97239
University of Pennsylvania Philadelphia Pennsylvania 19104
University of Texas Southwestern Medical Center Dallas Texas 75390-9191
University of Utah MidValley Dermatology Murray Utah 84107
Center for Clinical & Translational Science Salt Lake City Utah 84108

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03181893, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 13, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03181893 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →